Search Count: 12
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-07-05 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U0R |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TKX |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TNI |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1J |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1R |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U26 |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2B |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2I |
 |
Crystal Structure Of The Class D Beta-Lactamase Oxa-935 From Pseudomonas Aeruginosa, Orthorhombic Crystal Form
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2022-07-06 Classification: HYDROLASE Ligands: SO4 |
 |
Crystal Structure Of The Oxacillin-Hydrolyzing Class D Extended-Spectrum Beta-Lactamase Oxa-14 From Pseudomonas Aeruginosa
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-12-29 Classification: HYDROLASE Ligands: GOL, SO4 |
 |
Crystal Structure Of The Class D Beta-Lactamase Oxa-935 From Pseudomonas Aeruginosa, Monoclinic Crystal Form
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-12-29 Classification: HYDROLASE |
 |
1.75 Angstrom Resolution Crystal Structure Of The Toxic C-Terminal Tip Of Cdia From Pseudomonas Aeruginosa In Complex With Immune Protein
Organism: Pseudomonas aeruginosa, Enterobacter cloacae
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2019-05-01 Classification: TOXIN |